The Business Times
business-time-50
SUBSCRIBERS

亚太生命科学领域蓬勃发展，新加坡吸引国际生物科技风投公司

特朗普的关税政策或促使企业重新评估投资，但该领域的长期前景预计不会改变

google-preferred-sourceAdd BT as a preferred source
Tessa Oh

Tessa Oh

Published Sun, Oct 5, 2025 · 06:29 PM — Updated Tue, Oct 7, 2025 · 08:11 AM
    • 特朗普的药品关税对制药商的影响显而易见，但对研发创新药物的上游初创企业的影响则尚不明朗。
    • 特朗普的药品关税对制药商的影响显而易见，但对研发创新药物的上游初创企业的影响则尚不明朗。 照片：《商业时报》资料照片

    本文由AI辅助翻译

    查看原文

    在本系列报道中，《商业时报》深入探讨了新加坡生物科技领域的现状，并探索一个关键挑战：如何将其世界一流的研发成果转化为商业成功。

    系列首篇报道探讨了为何很少有本土公司在新加坡交易所上市的原因，本篇报道则将目光投向上游，随着国际生物科技风险投资公司纷纷涌入新加坡，我们发现了一幅更具活力的景象。后续报道将探讨该领域面临的宏观经济逆风以及行业的未来发展方向。

    【新加坡】受亚太地区日益壮大的生命科学领域的吸引，国际生物科技风险投资（VC）公司正纷纷涌入新加坡，并且已确认又有一家欧洲风投公司将在年底前在此设立业务。

    此翻译对您是否有帮助？

    Venture capitalTrump tariffsUS tariffsBiotechAsia-Pacific

    TRENDING NOW

    The Monetary Authority of Singapore said it is following up with the three Singapore entities to reinforce its expectations of conduct and compliance.

    Tiger Brokers, Moomoo, Longbridge Singapore units ‘financially independent’ amid China crackdown: MAS

    The departure of food manufacturing operations from Singapore may not necessarily be reason for concern.

    Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned

    KSL's Khoo Lee Feng says it is "not so much what you study, but how you learn".

    Johor property old hand KSL readies family handover amid market boom

    Nuclear power “is very much back in the conversation” in Asia, say industry observers.

    As India and China surge ahead with nuclear energy, all eyes on Asean’s next move

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More